14-88618273-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_183387.3(EML5):āc.5597T>Cā(p.Met1866Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,613,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_183387.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000161 AC: 40AN: 248986Hom.: 0 AF XY: 0.000215 AC XY: 29AN XY: 135084
GnomAD4 exome AF: 0.000148 AC: 217AN: 1461538Hom.: 0 Cov.: 30 AF XY: 0.000164 AC XY: 119AN XY: 727048
GnomAD4 genome AF: 0.000210 AC: 32AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000174 AC XY: 13AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2024 | The c.5597T>C (p.M1866T) alteration is located in exon 41 (coding exon 41) of the EML5 gene. This alteration results from a T to C substitution at nucleotide position 5597, causing the methionine (M) at amino acid position 1866 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at